Chinese firms should focus on investing in politically stable regions: entrepreneur



Chinese firms should prioritise regional political stability when they make overseas investment decisions, as mounting geopolitical tensions and currency fluctuations increase the risks of doing business abroad, a prominent Chinese entrepreneur has warned.

“The current unrest in the Middle East, fluctuations of the US dollar and international complexities serve as a reminder for firms expanding abroad: we must go to locations that offer relative stability,” said Liu Yonghao, founder and chairman of agricultural conglomerate New Hope Group.

As one of China’s leading entrepreneurs and overseas investors, Liu has been driving New Hope Group’s global expansion for nearly 30 years. He is also a member of the National Committee of the Chinese People’s Political Consultative Conference (CPPCC), the country’s top political advisory body.
“It is better for us to invest more in places that we understand relatively well and where we can have a better grasp of the situation,” he added, speaking on the sidelines of the “two sessions” – the annual meetings of China’s top legislature and the CPPCC – in Beijing on Tuesday.

Liu said he favoured regions such as Southeast Asia, Australia and New Zealand – whose markets are comparatively more predictable and geographically distant from conflict zones.

His comments came as an increasing number of Chinese firms look to overseas markets for new growth opportunities and an escape from sluggish demand and intensifying competition at home.

  • Related Posts

    Chinese robotaxi firms accelerate global roll-outs as cost edge drives expansion

    Chinese robotaxi firms from Pony AI to WeRide are accelerating global roll-outs of commercial fleets, leveraging cost competitiveness from the country’s world-leading new energy vehicle (NEV) supply chain and improved…

    Continue reading
    WuXi AppTec posts record first-quarter revenue on strong global demand

    China’s drug maker WuXi AppTec reported record first-quarter revenue, as a robust order backlog and sustained demand from global pharmaceutical companies supported growth. For the three months ended March 31,…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *